News

Ideas That Generate Results

The recent economic downturn has resulted in slow growth of the US pharma market, which is the world's largest pharma market. Consumers are now going for cheaper drugs. But despite the slowdown, the country will continue to dominate the global pharma market. According to our new research on the sector called "Global Pharmaceutical Market Forecast to 2012", the pharma market in the US is forecast to grow at a CAGR of around 3% during 2010-2012.

We have found that the focus of global pharma majors has been shifting towards Asia-Pacific and Latin American countries because of low cost factors. Most drug manufacturers had earlier ignored these markets due to their low pharmaceutical spending and questionable intellectual property protection. But today, irrespective of these issues, drug manufacturers are keen to launch their innovative products in these markets. Our report provides complete information on the pharma markets in the Asia-Pacific and Latin American countries. The report also studies and analyzes various factors that are promoting the growth of the market.

We have found that low cost generics is taking place of high cost therapies. The continuous expiration of patents has also supported this trend. We anticipate this trend will continue in near future also and generics will increase its share in the market. Besides, we have discovered that growing inorganically via way of Mergers and Acquisitions has emerged as the most practical way for the companies to expand and increase their reach at a faster rate as well as to maintain their revenues. We expect this trend to continue in near future also.
 
RNCOS' "Global Pharmaceutical Market Forecast to 2012" analyzes the key segments of industry to give a brief overview of the future scenario of the industry. Moreover, it includes information on the key competitors in the market along with their business description and area of expertise, which will help clients in devising their market strategies accordingly.

For more information visit: http://www.rncos.com/Report/IM149.htm